10-Q: Health Catalyst Reports Second Quarter 2024 Results, Revenue Stable, Losses Narrow

Health Catalyst's second quarter 2024 results show stable revenue and a reduction in net losses compared to the same period last year.

Summary

• Health Catalyst's second quarter 2024 revenue remained relatively stable at $75.9 million, compared to $73.2 million in the second quarter of 2023.
• Technology revenue was $47.6 million, while professional services revenue reached $28.3 million.
• The company reported a net loss of $13.5 million for the quarter, a significant improvement from the $32.6 million loss in the same quarter of the previous year.
• For the first six months of 2024, total revenue was $150.6 million, compared to $147.1 million in the first six months of 2023.
• The net loss for the first six months of 2024 was $34.1 million, compared to $65.8 million for the same period in 2023.
• Adjusted EBITDA for the second quarter of 2024 was $7.5 million, up from $3.5 million in the second quarter of 2023.
• Adjusted EBITDA for the first six months of 2024 was $10.9 million, compared to $7.7 million for the same period in 2023.

Sentiment

Score: 7

Explanation: The document shows a positive trend with reduced losses and improved EBITDA, but the company is still operating at a loss and faces significant risks. The strategic shift towards TEMS and the new credit facility are positive developments, but the company's future performance is still subject to market conditions and execution risks.

Positives

• The company has shown a significant reduction in net losses compared to the previous year.
• Adjusted EBITDA has improved year-over-year, indicating better operational performance.
• Revenue has remained stable, showing resilience in the current market.
• The company has made progress in reducing operating expenses as a percentage of revenue.

Negatives

• The company continues to operate at a net loss.
• Professional services gross margin is lower than technology gross margin.
• The company is experiencing some elevated churn levels, primarily for offerings that do not provide a near-term measurable financial ROI.

Risks

• The company operates in a highly competitive industry, and failure to compete effectively could harm the business.
• Macroeconomic challenges, including high inflation and interest rates, could negatively impact the business.
• Failure to manage growth and organizational change effectively could harm the business.
• Cyberattacks and data breaches could adversely affect the business.
• The company relies on third-party providers for infrastructure, and any disruptions could harm the business.
• The company's pricing may change over time, affecting its ability to attract or retain clients.
• The company's Solution is dependent on sourcing data from third parties, and any limitations on access could impair the business.
• The company's results of operations may fluctuate significantly, and failure to meet expectations could cause the stock price to decline.
• The company's term loan facility exposes it to interest rate risks and contains covenants that restrict its ability to take certain actions.

Future Outlook

The company anticipates improvement in 2024 bookings metrics and expects a higher proportion of net bookings in the second half of 2024. They also expect to migrate existing DOS Subscription Clients to the new Health Catalyst Ignite platform over the next two to three years.

Management Comments

• The company is proactively responding to the macroeconomic environment with a strategic operating plan that emphasizes offerings and go-to-market approach in areas where they have the most competitive differentiation and where clients are most likely to achieve measurable financial and operational ROI.
• The company believes this focus will enable them to move forward in a position of continued competitive and financial strength.
• The company will continue to refine this strategic operating plan and are continuing to make several investments in research and development, primarily in enhancing the capabilities within Health Catalyst Ignite, in order to maintain their position as a market-leading data platform over the long term.

Industry Context

The healthcare industry is experiencing financial strain due to increased labor and supply costs, which has led to a decrease in spending on technology and services. Health Catalyst is adapting to this environment by focusing on solutions that offer a near-term financial return on investment.

Comparison to Industry Standards

• While specific industry benchmarks are not provided in the document, the company's performance is compared to its own previous results, showing improvements in net loss and Adjusted EBITDA.
• The company's focus on recurring revenue and technology predictability aligns with industry trends for SaaS companies.
• The company's strategic shift towards Tech-enabled Managed Services (TEMS) reflects a response to the healthcare industry's need for near-term expense solutions, similar to other companies in the healthcare services sector.
• The company's modular pricing strategy for Health Catalyst Ignite is a common approach in the software industry to attract a broader range of clients.

Legal Proceedings

• The company was previously involved in a legal proceeding with Pascal Metrics, Inc., which was settled in June 2023.

Related Party Transactions

• The company has revenue arrangements with Carle Health, and a member of Carle Health's executive leadership team serves on the company's board of directors.

Stakeholder Impact

• Shareholders may see a positive impact from the reduced losses and improved EBITDA.
• Employees may be affected by the ongoing restructuring and cost reduction initiatives.
• Customers may benefit from the company's focus on solutions that offer a near-term financial return on investment.
• Creditors may be affected by the company's new credit agreement and its use of proceeds.

Next Steps

• The company will continue to refine its strategic operating plan.
• The company will continue to make investments in research and development, primarily in enhancing the capabilities within Health Catalyst Ignite.
• The company will continue to migrate existing DOS Subscription Clients to the new Health Catalyst Ignite platform over the next two to three years.

Key Dates

Keywords

healthcare analytics, data platform, professional services, technology subscriptions, EBITDA, net loss, revenue, financial results, healthcare technology, cloud-based platform